PandaOmics is a cloud-based software platform that applies artificial intelligence and bioinformatics techniques to multimodal omics and biomedical text data for therapeutic target and biomarker ...
Disease modeling and target identification are critical and time-consuming portions of the drug discovery process and areas where artificial intelligence (AI) is already making a substantial impact. A ...
When Insilico Medicine’s CEO Alex Zhavoronkov, PhD, and his co-authors wrote their 2023 opinion paper on AI-powered target discovery, 1 he was thinking about how often target discovery is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results